Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine versus olanzapine for insomnia in bipolar disorder
IRCT20100127003210N31Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Insomnia and bipolar disorder (BD) comparing Olanzapine arm with Agomelatine arm (2 arms). Primary endpoints: Weight, Insomnia Severity Index score and 1 more. Started Jun 2025; status: completed.
02
Drugs
agomelatineolanzapine
03
Conditions
Insomniabipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20100127003210N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N31.